181 related articles for article (PubMed ID: 26702077)
1. Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy-Associated Cardiomyopathy.
Parvatiyar MS; Marshall JL; Nguyen RT; Jordan MC; Richardson VA; Roos KP; Crosbie-Watson RH
J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702077
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.
Parvatiyar MS; Brownstein AJ; Kanashiro-Takeuchi RM; Collado JR; Dieseldorff Jones KM; Gopal J; Hammond KG; Marshall JL; Ferrel A; Beedle AM; Chamberlain JS; Renato Pinto J; Crosbie RH
JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31039133
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy.
Shu C; Parfenova L; Mokhonova E; Collado JR; Damoiseaux R; Campagna J; John V; Crosbie RH
Skelet Muscle; 2020 Sep; 10(1):26. PubMed ID: 32948250
[TBL] [Abstract][Full Text] [Related]
4. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
Oliveira-Santos A; Dagda M; Burkin DJ
Hum Mol Genet; 2022 Jul; 31(14):2358-2369. PubMed ID: 35157045
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine decreases cardiac fibrosis and improves cardiac function in a mouse model of Duchenne muscular dystrophy.
Hirata T; Baba S; Akagi K; Matsuda K; Umeda K; Adachi S; Heike T; Takita J
PLoS One; 2024; 19(1):e0297083. PubMed ID: 38295120
[TBL] [Abstract][Full Text] [Related]
6. Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.
Rafael-Fortney JA; Chimanji NS; Schill KE; Martin CD; Murray JD; Ganguly R; Stangland JE; Tran T; Xu Y; Canan BD; Mays TA; Delfín DA; Janssen PM; Raman SV
Circulation; 2011 Aug; 124(5):582-8. PubMed ID: 21768542
[TBL] [Abstract][Full Text] [Related]
7. Sarcospan increases laminin-binding capacity of α-dystroglycan to ameliorate DMD independent of Galgt2.
Mamsa H; Stark RL; Shin KM; Beedle AM; Crosbie RH
Hum Mol Genet; 2022 Mar; 31(5):718-732. PubMed ID: 34581784
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted view of heart problem in Duchenne muscular dystrophy.
Florczyk-Soluch U; Polak K; Dulak J
Cell Mol Life Sci; 2021 Jul; 78(14):5447-5468. PubMed ID: 34091693
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy.
Adamo CM; Dai DF; Percival JM; Minami E; Willis MS; Patrucco E; Froehner SC; Beavo JA
Proc Natl Acad Sci U S A; 2010 Nov; 107(44):19079-83. PubMed ID: 20956307
[TBL] [Abstract][Full Text] [Related]
10. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice.
Duclos F; Straub V; Moore SA; Venzke DP; Hrstka RF; Crosbie RH; Durbeej M; Lebakken CS; Ettinger AJ; van der Meulen J; Holt KH; Lim LE; Sanes JR; Davidson BL; Faulkner JA; Williamson R; Campbell KP
J Cell Biol; 1998 Sep; 142(6):1461-71. PubMed ID: 9744877
[TBL] [Abstract][Full Text] [Related]
11. Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model.
Howard ZM; Dorn LE; Lowe J; Gertzen MD; Ciccone P; Rastogi N; Odom GL; Accornero F; Chamberlain JS; Rafael-Fortney JA
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33651713
[TBL] [Abstract][Full Text] [Related]
12. Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular Dystrophy.
Paleo BJ; McElhanon KE; Bulgart HR; Banford KK; Beck EX; Sattler KM; Goines BN; Ratcliff SL; Crowe KE; Weisleder N
Cells; 2022 Apr; 11(9):. PubMed ID: 35563723
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model.
Sullivan RT; Lam NT; Haberman M; Beatka MJ; Afzal MZ; Lawlor MW; Strande JL
BMC Cardiovasc Disord; 2021 Jun; 21(1):302. PubMed ID: 34130633
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous abnormalities of in-vivo left ventricular calcium influx and function in mouse models of muscular dystrophy cardiomyopathy.
Greally E; Davison BJ; Blain A; Laval S; Blamire A; Straub V; MacGowan GA
J Cardiovasc Magn Reson; 2013 Jan; 15(1):4. PubMed ID: 23324314
[TBL] [Abstract][Full Text] [Related]
15. RANKL Inhibition Reduces Cardiac Hypertrophy in
Marcadet L; Juracic ES; Khan N; Bouredji Z; Yagita H; Ward LM; Tupling AR; Argaw A; Frenette J
Cells; 2023 Jun; 12(11):. PubMed ID: 37296659
[TBL] [Abstract][Full Text] [Related]
16. Systemic under treatment of heart disease in patients with Duchenne muscular dystrophy.
Karachunski P; Townsend D
Neuromuscul Disord; 2023 Oct; 33(10):776-781. PubMed ID: 37775424
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of dilated cardiomyopathy in Duchenne muscular dystrophy: A systematic review.
Haddad CN; Ali S; Stephanou D; Assakura MS; Sahagian L; Trogkanis E
Hellenic J Cardiol; 2023; 74():58-64. PubMed ID: 37406964
[TBL] [Abstract][Full Text] [Related]
18. Functional cardiac consequences of β-adrenergic stress-induced injury in the
Earl CC; Javier AJ; Richards AM; Markham LW; Goergen CJ; Welc SS
bioRxiv; 2024 Apr; ():. PubMed ID: 38659739
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection and Suppression of Fibrosis by Diverse Cancer and Non-Cancer Cell Lines in a Murine Model of Duchenne Muscular Dystrophy.
Achlaug L; Langier Goncalves I; Aronheim A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673859
[TBL] [Abstract][Full Text] [Related]
20. Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.
Fine DM; Shin JH; Yue Y; Volkmann D; Leach SB; Smith BF; McIntosh M; Duan D
Neuromuscul Disord; 2011 Jul; 21(7):453-61. PubMed ID: 21570848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
